When clinicians must override the machine: verifying AI-assisted diagnoses and treatment plans

Clinicians remain the final arbiters of diagnosis and treatment. This post deep-dives into what that responsibility means in practice, with concrete steps, system-level safeguards and references to current clinical guidance.

Why clinicians still bear responsibility

AI tools are increasingly integrated into clinical workflows as diagnostic aids or treatment suggestion systems. They can improve efficiency and surface patterns that a busy clinician might miss. But multiple legal analyses and professional guidance make one thing clear: clinicians cannot abdicate clinical judgement to an algorithm. Regulatory and professional bodies expect a clinician to verify and be able to explain diagnoses and plans that rely on AI outputs.

What the evidence and guidance say

Three types of sources converge on the same point. Manuals on diagnosis emphasise the value of consultation and second opinions to confirm or reject a working diagnosis, especially when a case falls outside a clinicians expertise. The National Academy of Medicine and the NCBI summarise this longstanding clinical practice of seeking additional expertise or referral when uncertainty exists. The US CDCs diagnostic excellence programme recommends explicit practices to manage diagnostic uncertainty, such as reflective review and "diagnostic timeouts", and encourages using decision-support tools as one of several inputs rather than a sole authority.

Importantly, the Federation of State Medical Boards states that physicians retain ultimate responsibility for explaining components of diagnosis and treatment, including during encounters where AI has informed recommendations. Informed consent must remain a meaningful dialogue; AI can assist, but the clinician must be able to explain options and rationale to the patient.

Practical guidance for clinicians: a checklist to verify AI outputs

Contextualise the output: Compare the AI suggestion against the patients history, examination findings and investigations. Treat the AI output as a hypothesis to be corroborated, not a final verdict.
Seek corroboration: When in doubt, consult a colleague or specialist. Formal consults and second opinions are standard practice for uncertain or complex cases and are recommended in diagnostic literature.
Use a diagnostic timeout: Pause to reflect when an AI recommendation conflicts with your clinical sense, when a case is atypical, or when the consequences of a wrong decision are high. The CDC endorses structured reflection as a safety practice.
Document reasoning and limitations: Record why you accepted, modified or rejected an AI output. Note whether the AI had known limitations for the case (e.g. outside its training population) or low confidence scores.
Preserve explainability for the patient: Be prepared to explain the reasoning to the patient in plain language. Meaningful informed consent requires the clinician to translate AI-driven suggestions into options the patient understands.
Know the tools scope and performance: Understand the data the AI was trained on, its intended use, and common failure modes. That knowledge should inform whether you rely on its output in a particular case.
Escalate when necessary: If an AI output suggests a high-risk action that you cannot validate, seek specialist input or arrange timely referral rather than proceeding without confirmation.
Contribute to feedback loops: Report mismatches between AI recommendations and clinical reality to the vendor or local governance team so the system can be improved.

Sociotechnical measures that reduce risk

Responsibility sits not only with the individual clinician but within a sociotechnical system. Organisations should design workflows and support structures that make it easy to exercise good judgement.

Integrate decision-support outputs into the workflow so clinicians see provenance, confidence and key inputs at the point of care.
Train clinicians on how to interpret AI outputs, including common biases and blind spots of the model.
Create non-punitive forums to discuss diagnostic errors and near-misses. The CDC highlights the need for safe environments to examine diagnostic safety events.
Define escalation pathways and make specialist access straightforward for ambiguous cases.
Ensure documentation templates prompt clinicians to record their independent reasoning and the role of AI in the decision.

Communicating with patients and legal considerations

Clinicians should maintain a transparent conversation about how AI was used in decision-making. The FSMB guidance emphasises that informed consent is a dialogue, not a checklist of AI-generated risks and benefits. Practically, this means explaining what the AI contributed, what uncertainties remain and why you recommend a particular plan.

From a medico-legal perspective, reliance on AI does not absolve the clinician of responsibility. Failure to exercise judgement and to verify an AI output risks liability if a patient is harmed. The protections come from good clinical practice: consultation, documentation, reflection and communication.

One practical vignette

A radiology AI flags a suspected pulmonary embolus in a patient with atypical symptoms. Rather than accepting the AIs call, the clinician reviews the scan, correlates with oxygenation, D-dimer and clinical risk scores, documents the discordance, consults a radiologist and discusses risks and next steps with the patient. If the clinician proceeds to anticoagulation, they do so with documented rationale and shared decision-making.

Expanded from

This post expands on a point from Sociotechnical systems in software and AI: Who bears the risk when AI-assisted medical decisions go wrong?.